White Label Rx for cash-pay

White Label Rx for cash-pay: DTC brand economics vs clinic ordering

White Label Rx is a DTC telehealth brand-launch platform, not a cash-pay clinic ordering portal. For a cash-pay clinic that already has patients, the core economics question is the spread between landed 503A per-vial cost and patient price. White Label Rx bundles its pharmacy economics into a consumer DTC model — not a pass-through catalog where a prescriber sees per-vial cost before quoting a patient. That distinction changes how cash-pay margin works on each platform.

If you run a cash-pay or concierge clinic and are evaluating White Label Rx to understand how its economics would affect your per-vial cost and patient pricing, this page explains the model and how Fizy Health's pass-through approach makes margin visible before you quote.

Cash-pay margin visibility DTC subscription vs clinic batch ordering Platform fee from $499/mo $7,500 White Glove setup Bundled DTC pharmacy economics No per-vial pass-through catalog

What does White Label Rx mean for cash-pay economics?

For a cash-pay clinic operator, White Label Rx is either a brand-launch investment or an irrelevant category depending on whether you already have patients. If you are building a new DTC telehealth brand that sells weight loss, hair loss, sexual health, or longevity programs to consumers at cash-pay prices, White Label Rx bundles the storefront, physician network, and pharmacy fulfillment for that model starting at $499 per month with setup fees and a $7,500 White Glove option. If you already run a cash-pay clinic with a patient panel and need to understand what you pay per vial on compounded GLP-1s before you quote a patient, White Label Rx does not show that number — its pharmacy fulfillment is integrated into a consumer DTC model, not a prescriber-side pass-through catalog.

Who feels the economics

Cash-pay margin is set by what each role can see before the patient pays.

In a cash-pay model, pricing visibility flows through three roles. Each one needs different clarity to protect margin — and each one's experience differs on White Label Rx versus a clinic ordering platform.

  • Owners

    Founders setting patient program prices.

    On White Label Rx, a DTC brand founder sets patient prices based on the subscription model and platform economics — not by looking up per-vial 503A landed cost in a catalog. On a clinic ordering platform with pass-through pricing, an owner sees resolved per-vial 503A cost before checkout and sets patient prices off that real number. The margin calculation is structurally different between the two models.

  • Operators

    Ops leads managing subscription economics.

    On White Label Rx, an operations lead manages patient subscriptions, refills, affiliate commissions, and the Go High Level CRM — DTC growth metrics. On a clinic ordering platform, an operations lead manages batch prescription accuracy, rejected order rates, and per-line shipping costs on today's refill list. These are fundamentally different daily workflows and economic concerns.

  • Prescribers

    Providers quoting at the visit in cash-pay.

    In a traditional cash-pay clinic, a prescriber or front-desk staff often quotes a patient's cost during the consultation. When that cost comes from a DTC subscription model rather than a visible per-vial catalog, the visit-time quoting conversation relies on estimated program prices rather than the real landed cost per dose. Pass-through pricing on a clinic ordering platform solves this by showing the live cost before checkout.

What drives cash-pay economics on White Label Rx

White Label Rx is a DTC subscription model. Patients pay for a treatment program — weight loss, hair loss, sexual health, longevity — through the branded storefront, and the platform's pharmacy network (GoGoMeds recommended, supporting 502A and 503B) fulfills the prescription. The platform costs for the brand operator are the monthly subscription ($499/mo for CORE and GROWTH, custom for White Glove) plus the $7,500 setup fee on White Glove, plus the economics of the pharmacy network embedded in the DTC model. There is no public per-vial pass-through catalog where an operator can compare landed cost on semaglutide 0.25mg versus 0.5mg before quoting a patient.

For a cash-pay clinic that already has patients, those are the wrong economics. The clinic's margin is the spread between what it pays per vial at the 503A compounder and what it charges the patient. A platform that bundles pharmacy economics into a consumer subscription model does not give the clinic the per-vial cost visibility it needs to protect that spread before the consult.

How pass-through pricing changes cash-pay margin

Fizy Health takes a pass-through approach built for cash-pay margin. It shows resolved 503A per-vial cost on every catalog and cart line before checkout, with a disclosed facilitation fee at payment — so the owner sets patient prices on the same number the clinic will actually pay, and the prescriber can quote at the visit on live cost. There is no DTC subscription markup embedded in the pharmacy economics; the drug cost passes through and the platform fee is stated at checkout.

On the operations side, one clinic cart batches the refill day and cart validation catches invalid SIGs, prescriber state mismatches, and stock gaps before payment, so the clinic stops paying for orders that get rejected after checkout. For a cash-pay clinic, the combined effect is margin you can see before you order and fewer surprises that quietly erode the spread — which is a different problem from managing a DTC subscription brand.

Which model fits a cash-pay clinic's actual economic problem?

White Label Rx fits if

White Label Rx

You are building a DTC cash-pay brand from zero.

  • You are launching a new consumer-facing telehealth brand with subscription-based cash-pay programs, not running an existing clinic.
  • You need the storefront, physician network, and pharmacy bundled into one DTC brand-launch investment.
  • A $499/mo platform fee and $7,500 White Glove setup fit a new-brand business plan, not an existing clinic P&L.
Consider Fizy Health if

Fizy Health

You already have cash-pay patients and need per-vial cost before the consult.

  • You set patient program prices off landed cost and need per-vial 503A cost visible before checkout.
  • You want the facilitation fee disclosed at payment with no DTC brand-model markup embedded in pharmacy economics.
  • You batch cash-pay refills across multiple 503A partners and need one cart, one validation pass, one checkout.
FAQ

What cash-pay operators ask about White Label Rx.

  • Definition

    What is White Label Rx for cash-pay operations?

    White Label Rx is a DTC telehealth brand-launch platform that gives entrepreneurs a consumer storefront, EHR, CRM, physician network, and pharmacy fulfillment for subscription-based cash-pay health programs. It is not a cash-pay clinic ordering portal where a prescriber sees per-vial landed cost before quoting an existing patient.

  • Pricing

    Does White Label Rx show per-vial cost before you quote a cash-pay patient?

    No. White Label Rx bundles its pharmacy economics through a partner network (GoGoMeds recommended) within a DTC subscription model. There is no public per-vial pass-through catalog where an existing clinic prescriber can see landed cost before the patient consultation. Fizy Health shows resolved per-vial 503A cost on each catalog and cart line before checkout, which enables visit-time quoting on live numbers.

  • Fees

    What should cash-pay clinics ask about White Label Rx costs?

    The platform costs for a White Label Rx brand are $499 per month for CORE or GROWTH plans (with applicable setup fees) and a $7,500 setup fee for the White Glove tier. For an existing cash-pay clinic evaluating whether these costs improve their per-vial ordering economics, the question is whether the DTC brand stack solves their actual problem — which for most existing clinics is not brand launch, but prescription batch efficiency and cost visibility.

  • Margin

    How does the White Label Rx model affect cash-pay margin?

    White Label Rx is a DTC subscription model where patient revenue is set by the brand's program pricing and the pharmacy economics are embedded in the platform's pharmacy network. A traditional cash-pay clinic that needs to protect the spread between per-vial landed cost and patient price needs visible pass-through pricing — not DTC subscription economics.

  • Visibility

    Can I compare per-vial 503A cost across compounders on White Label Rx?

    No. White Label Rx routes orders through its recommended pharmacy partner (GoGoMeds, supporting 502A and 503B) and compatible network pharmacies, but does not present a per-compounder pass-through catalog for operator cost comparison. Fizy Health shows per-vial 503A cost by compounder on each catalog and cart line before checkout, enabling direct comparison across assigned 503A partners.

  • Alternative

    How does Fizy Health change cash-pay economics for existing clinics?

    Fizy Health shows pass-through per-vial 503A cost before checkout with a disclosed facilitation fee, batches the refill day in one validated cart, and catches rejections before payment — so cash-pay clinics set prices on visible landed cost and lose less margin to post-pay surprises. Free to join, with no monthly platform fee on the Free plan.

Sources reviewed June 2026

  • White Label Rx public website (whitelblrx.com), reviewed June 2026.
  • Fizy Health platform capabilities reflect the live product.
Evaluate with real numbers

See cash-pay margin before you order.

See how Fizy Health shows landed 503A cost before you quote, validates orders before you pay, and batches the whole refill day in one checkout. Free to start.